Sinclair Pharma PLC | Ownership
Companies that own Sinclair Pharma PLC
Toscafund Asset Management LLP
148,613,603
29.5%
2,500,000
2.83%
07/09/2018
Lansdowne Partners (UK) LLP
59,987,523
11.91%
0
0.14%
07/10/2018
Fidelity Management & Research Co.
38,003,065
7.54%
10,152,471
0%
07/05/2018
Litespeed Management LLC
20,478,340
4.07%
20,478,340
7.6%
07/23/2018
Soros Fund Management LLC
19,456,023
3.86%
-5,543,977
0.13%
01/11/2018
Schroder Investment Management Ltd.
16,931,971
3.36%
-8,206,100
0%
07/05/2018
UBS Securities LLC
16,458,000
3.27%
0
0.01%
07/02/2018
Mirabaud Asset Management Ltd.
10,582,196
2.1%
-5,170,312
0.37%
07/25/2018
Jefferies LLC
7,100,000
1.41%
0
3.41%
07/02/2018
Hargreaves Lansdown Stockbrokers Ltd.
5,976,000
1.19%
776,000
0.01%
07/02/2018
| Address |
Whitfield Court
London Greater London W1T 2RQ
United Kingdom
|
|
Employees
|
- |
| Website |
http://sinclairispharma.com |
| Updated |
09/14/2018 |
| Sinclair Pharma Plc is an aesthetic dermatology company, which provides aesthetic dermatology solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations, and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. |
